SCHEMBL13615698

SCHEMBL13615698

Cc1ccc(N(c2ccc(C)cc2)c2ccc(-c3c4ccc(N(c5ccccc5)c5ccc6c(c5)c5ccccc5n6-c5ccccc5)cc4c(-c4ccc(N(c5ccc(C)cc5)c5ccc(C)cc5)cc4)c4ccc(N(c5ccccc5)c5ccc6c(c5)c5ccccc5n6-c5ccccc5)cc34)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.42
ATM Q13315 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
PTGER4 P35408 1/20 0.35
KMT2A Q03164 3/20 0.34
ALDH1A1 P00352 6/20 0.34
RXFP1 Q9HBX9 1/20 0.34
AKR1C4 P17516 1/20 0.34
AKR1C3 P42330 1/20 0.34
AKR1C2 P52895 1/20 0.34
AKR1C1 Q04828 1/20 0.34
SIRT2 Q8IXJ6 1/20 0.33
SIRT1 Q96EB6 1/20 0.33
PDE9A O76083 1/20 0.33
PDE1C Q14123 1/20 0.33
HPGD P15428 3/20 0.33
GAA P10253 3/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
GFER P55789 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14362646 0.97 KDM4E (0.41) KDM4EATML3MBTL1PTGER4KMT2A
SCHEMBL14521311 0.95 KDM4E (0.40) KDM4EATML3MBTL1PTGER4KMT2A
SCHEMBL14521312 0.95 KDM4E (0.40) KDM4EATML3MBTL1PTGER4KMT2A
SCHEMBL14362613 0.95 KDM4E (0.40) KDM4EATML3MBTL1PTGER4KMT2A
SCHEMBL13209232 0.95 KDM4E (0.41) KDM4EATML3MBTL1KMT2AALDH1A1
SCHEMBL10098656 0.95 KDM4E (0.41) KDM4EATML3MBTL1PTGER4KMT2A
SCHEMBL10098600 0.95 KDM4E (0.41) KDM4EATML3MBTL1PTGER4KMT2A
SCHEMBL14362640 0.94 KDM4E (0.36) KDM4EATML3MBTL1PTGER4KMT2A
SCHEMBL10098646 0.94 KDM4E (0.40) KDM4EATML3MBTL1PTGER4KMT2A
SCHEMBL13615642 0.94 L3MBTL1 (0.47) KDM4EATML3MBTL1PTGER4KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090273277-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2009-11-05 US disclosed
US-20090273277-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2009-11-05 US disclosed
EP-2103666-A2 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2009-09-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090273277-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, ORMDL3, CHRM2 KDM4E 3872/4885ATM 4684/4885L3MBTL1 283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.